Conceptio › Archive › Springer Nature OA
Springer Nature OAopen access

Canagliflozin attenuates CMR-quantified myocardial fibrosis in individuals with type 2 diabetes mellitus at high cardiovascular risk: a randomised open-label controlled trial

Yan, Hongmei et al.
Springer Nature OA · Papers · License: Open Access
Open Source ↗
Medicine & Public Health, Internal Medicine, Metabolic Diseases, Human Physiology
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗
Record · ID 130677
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.